» Articles » PMID: 25345340

Antimicrobial Activity of Platelet-rich Plasma and Other Plasma Preparations Against Periodontal Pathogens

Overview
Journal J Periodontol
Date 2014 Oct 28
PMID 25345340
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In addition to releasing a pool of growth factors during activation, platelets have many features that indicate their role in the anti-infective host defense. The antimicrobial activities of platelet-rich plasma (PRP) and related plasma preparations against periodontal disease-associated bacteria were evaluated.

Methods: Four distinct plasma fractions were extracted in the formulation used commonly in dentistry and were tested for their antibacterial properties against three periodontal bacteria: Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Fusobacterium nucleatum. The minimum inhibitory concentration of each plasma preparation was determined, and in vitro time-kill assays were used to detect their abilities to inhibit bacterial growth. Bacterial adhesion interference and the susceptibility of bacterial adherence by these plasma preparations were also conducted.

Results: All plasma preparations can inhibit bacterial growth, with PRP showing the superior activity. Bacterial growth inhibition by PRP occurred in the first 24 hours after application in the time-kill assay. PRP interfered with P. gingivalis and A. actinomycetemcomitans attachment and enhanced exfoliation of attached P. gingivalis but had no influences on F. nucleatum bacterial adherence.

Conclusions: PRP expressed antibacterial properties, which may be attributed to platelets possessing additional antimicrobial molecules. The application of PRP on periodontal surgical sites is advisable because of its regenerative potential and its antibacterial effects.

Citing Articles

Low-Speed Platelet-Rich Fibrin Membrane in Conjunction With Demineralized Freeze-Dried Bone Allograft (DFDBA) Compared to Collagen Membrane With DFDBA in Noncontained Intraosseous Defects of Stage III Periodontitis: A Randomized Controlled Clinical....

Almoliky N, Hosny M, Elbattawy W, Fawzy El-Sayed K Int J Dent. 2025; 2025:6393105.

PMID: 40028653 PMC: 11872290. DOI: 10.1155/ijod/6393105.


Evaluation of leukocyte-platelet rich fibrin as an antibiotic slow-release biological device in the treatment of moderate periodontitis: a randomized controlled clinical trial.

Omar Y, Rashidy M, Ahmed G, Aboulela A BMC Oral Health. 2024; 24(1):1530.

PMID: 39709402 PMC: 11662799. DOI: 10.1186/s12903-024-05254-x.


How to explain the beneficial effects of leukocyte- and platelet-rich fibrin.

Blanco J, Garcia A, Garcia Alonso A, Hermida-Nogueira L, Castro A Periodontol 2000. 2024; 97(1):74-94.

PMID: 38923566 PMC: 11808445. DOI: 10.1111/prd.12570.


From Basic Science to Clinical Practice: A Review of Current Periodontal/Mucogingival Regenerative Biomaterials.

De Lauretis A, Ovrebo O, Romandini M, Lyngstadaas S, Rossi F, Haugen H Adv Sci (Weinh). 2024; 11(17):e2308848.

PMID: 38380549 PMC: 11077667. DOI: 10.1002/advs.202308848.


The impact of local and systemic penicillin on antimicrobial properties and growth factor release in platelet-rich fibrin: In vitro study.

Ozcan M, Kabakli S, Alkaya B, Isler S, Turer O, Oksuz H Clin Oral Investig. 2023; 28(1):61.

PMID: 38157066 DOI: 10.1007/s00784-023-05428-x.